IL-1β-Triggered Long Non-coding RNA CHRF Induces Non-Small Cell Lung Cancer by Modulating the microRNA-489/Myd88 Axis

Zhang, Yamei; Zhang, Yabo; Zeng, Qianglin; Li, Ci; Zhou, Hui; Liu, Junying; Shi, Zheng; Ma, Li

doi:10.7150/jca.63256



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2022; 13(8):2620-2630. doi:10.7150/jca.63256 This issue Cite

Research Paper

IL-1β-Triggered Long Non-coding RNA CHRF Induces Non-Small Cell Lung Cancer by Modulating the microRNA-489/Myd88 Axis

Yamei Zhang^1✉#, Yabo Zhang^2#, Qianglin Zeng², Ci Li³, Hui Zhou², Junying Liu¹, Zheng Shi¹, Li Ma^4✉

1. Clinical Genetics Laboratory, Affiliated Hospital & Clinical Medical College of Chengdu University, Chengdu 610081, P.R. China.
2. Department of Respiratory and Critical Care Medicine, Affiliated Hospital & Clinical Medical College of Chengdu University, Chengdu 610081, P.R. China.
3. Department of Pathology, Affiliated Hospital & Clinical Medical College of Chengdu University, Chengdu 610081, P.R. China.
4. Institute of Blood Transfusion, Chinese Academy of Medical Sciences, Chengdu 610052, P.R. China.
#These authors are regarded as co-first authors.

Citation:

Zhang Y, Zhang Y, Zeng Q, Li C, Zhou H, Liu J, Shi Z, Ma L. IL-1β-Triggered Long Non-coding RNA CHRF Induces Non-Small Cell Lung Cancer by Modulating the microRNA-489/Myd88 Axis. J Cancer 2022; 13(8):2620-2630. doi:10.7150/jca.63256. https://www.jcancer.org/v13p2620.htm

Other styles

Abstract

Background: Long noncoding RNAs (LncRNAs) possess crucial roles in carcinogenesis. The current study aims to evaluate the effects of interleukin-1β (IL-1β)-mediated lncRNA cardiac hypertrophy-related factor (CHRF)/microRNA-489 (miR-489)/myeloid differentiation factor 88 (Myd88) on non-small-cell lung cancer (NSCLC).

Methods: Initially, the expression of IL-1β and lncRNA CHRF in NSCLC cells and tissues was determined, respectively. H460 cell line with highest lncRNA CHRF expression was selected for in vitro experimentations. Afterward, the interaction among lncRNA CHRF, miR-489, and Myd88 was verified with their significance in cell functions and tumorigenicity and lung metastasis analyzed following.

Results: IL-1β and lncRNA CHRF was remarkably upregulated in NSCLC. IL-1β was able to elevate lncRNA CHRF expression. Additionally, lncRNA CHRF targeted miR-489 and miR-489 targeted Myd88. Moreover, functional assay results suggested that under IL-1β treatment, lncRNA CHRF induced NSCLC cell malignant properties and tumorigenicity and lung metastasis through modulation of miR-489/Myd88 axis.

Conclusion: Taken together, our findings revealed that IL-1β-induced elevation of lncRNA CHRF aggravated NSCLC through modulation of miR-489/Myd88 axis, which provides a novel direction for NSCLC therapy development.

Keywords: Long noncoding RNA cardiac hypertrophy-related factor, microRNA-489, Myeloid differentiation factor 88, Interleukin-1β, Non-small cell lung cancer, Proliferation, Migration, Invasion, Apoptosis

Citation styles

APA

Zhang, Y., Zhang, Y., Zeng, Q., Li, C., Zhou, H., Liu, J., Shi, Z., Ma, L. (2022). IL-1β-Triggered Long Non-coding RNA CHRF Induces Non-Small Cell Lung Cancer by Modulating the microRNA-489/Myd88 Axis. Journal of Cancer, 13(8), 2620-2630. https://doi.org/10.7150/jca.63256.

ACS

Zhang, Y.; Zhang, Y.; Zeng, Q.; Li, C.; Zhou, H.; Liu, J.; Shi, Z.; Ma, L. IL-1β-Triggered Long Non-coding RNA CHRF Induces Non-Small Cell Lung Cancer by Modulating the microRNA-489/Myd88 Axis. J. Cancer 2022, 13 (8), 2620-2630. DOI: 10.7150/jca.63256.

NLM

CSE

Zhang Y, Zhang Y, Zeng Q, Li C, Zhou H, Liu J, Shi Z, Ma L. 2022. IL-1β-Triggered Long Non-coding RNA CHRF Induces Non-Small Cell Lung Cancer by Modulating the microRNA-489/Myd88 Axis. J Cancer. 13(8):2620-2630.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.